SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 24, 2003
Specialty Laboratories, Inc.
(Exact name of registrant as specified in charter)
|
California |
|
001-16217 |
|
95-2961036 |
|
(State or other
jurisdiction |
|
(Commission |
|
(IRS Employer |
|
2211 Michigan Avenue, Santa Monica, California |
|
90404 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code (310) 828-6543
(Former name or former address, if changed since last report.)
ITEM 7 FINANCIAL STATEMENTS AND EXHIBITS
|
(c) |
|
Exhibits |
|
The following document is filed as an exhibit to this report: |
|
|
|
|
|
|
|
|
|
99.1 |
|
Press Release dated April 24, 2003. |
ITEM 9 REGULATION FD DISCLOSURE
This information is being furnished under Item 12 of Form 8-K and is being presented under Item 9 in accordance with the Securities and Exchange Commission’s interim guidance regarding Form 8-K Item 12 filing requirements, as set forth in Release No. 33-8216.
On April 24, 2003, Specialty Laboratories, Inc., (the “Registrant”) announced financial results for the first quarter ended March 31, 2003. A copy of the press release issued by the Registrant on April 24, 2003 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Specialty Laboratories, Inc. |
|||
|
|
|
|
||
|
|
|
|
||
|
Date: April 24, 2003 |
By: |
/s/ FRANK J. SPINA |
|
|
|
|
|
Frank J. Spina, |
||
|
|
|
Chief Financial Officer |
||
3
EXHIBIT INDEX
|
Exhibits |
|
The following document is filed as an exhibit to this report: |
|
|
|
|
|
99.1 |
|
Press Release dated April 24, 2003. |
4